Skip to main content
Domenic Ciraulo, MD, Psychiatry, Falmouth, MA

DomenicACirauloMD

Psychiatry Falmouth, MA

Addiction, Psychopharmacology

Professor and Chair, Department of Psychiatry, Boston University School of Medicine

Dr. Ciraulo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ciraulo's full profile

Already have an account?

Education & Training

  • Harvard Medical School
    Harvard Medical School1977 - 1978
  • Massachusetts Mental Health Center
    Massachusetts Mental Health CenterChief Residency, Somatic Therapies, 1977 - 1978
  • Institute of Living
    Institute of Living1975 - 1977
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1975
  • University of Hartford
    University of HartfordBS, Summa cum Laude, 1971

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1977 - 2017
  • CT State Medical License
    CT State Medical License 1976 - 2016

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Boston Magazine Castle Connolly, 2010-2013
  • Listed in The Best Doctors in America Woodward/White, Inc, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Benzodiazepine treatment of specific anxiety states.  
    Shader RI, Greenblatt DJ, Ciraulo DA, Psychiatric Annals 11:30-40
  • Question the experts, disulfiram-MAOI interactions.  
    Ciraulo DA, J Clin Psychopharm 9:315-316
  • Question the experts, buspirone-MAOI interactions.  
    Ciraulo DA, Shader RI, J Clin Psychopharm 10:306
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Toxicokinetic dose-response models of mortality in toxicity studies.
    Neafsey P, Boxenbaum H, Ciraulo D, Fournier D, American Association of Pharmaceutical Scientists Annual Meeting, Washington, DC
  • Age effects on benzodiazepine receptor binding following acute and chronic defeat stress in mice.
    Barnhill JG, Thompson ML, Miller LG, Greenblatt DJ, Ciraulo DA, Shader RI, American College of Clinical Pharmacology Annual Meeting, Orlando, FL
  • Benzodiazepine response and receptor binding following chronic ethanol consumption in a mouse model.
    Barnhill JG, Ciraulo DA, Greenblatt DJ, Faggart M, Harmatz J, American College of Clinical Pharmacology Annual Meeting, Las Vegas, NV
  • Join now to see all

Grant Support

  • Interdisciplinary Study Of Two Novel Anticonvulants In AlcoholismNational Institute On Alcohol Abuse And Alcoholism2009–2012
  • Cognitive-Behavioral Therapy &Venlafaxine Treatments For Anxiety In AlcoholismNational Institute On Alcohol Abuse And Alcoholism2007
  • Assessment Of Interaction Of Cocaine And Quetiapine (SEROQUEL)National Center For Research Resources2006
  • CBT And Venlafaxine Treatments For Anxiety In AlcoholismNational Institute On Alcohol Abuse And Alcoholism2003–2006
  • Assessment Of Interaction Of Cocaine And QuetiapineNational Center For Research Resources2005
  • Neuroimaging Collaborative Study/TiagabineNational Center For Research Resources2004–2005
  • Boston University Cru For Alcoholism TreatmentNational Institute On Alcohol Abuse And Alcoholism1997–2004
  • Assessment Of IV Cocaine Using Pharmacokinetic/Pharmacodynamic EffectNational Center For Research Resources1999–2002
  • Naltrexone And Acamprosate With And Without Challenge In Alcohol DependentNational Center For Research Resources2001
  • Naltrexone And Acamprosate W/ Challenge In Alcohol DepenNational Center For Research Resources2000
  • Sublingual Buprenorphine In Nondependent Opiate UsersNational Center For Research Resources1998–2000
  • BZ Receptor Effects Of Prenatal Ethanol/BensodiazepineNational Institute On Drug Abuse1990–1991